Mutations in PALB2/FANCN increase breast and pancreatic cancer incidence, while truncating variants of BRIP1/FANCJ and RAD51C/FANCO increase ovarian [108,109] but not breast cancer [110]. This evidence concerns the gene PALB2 and pancreatic neoplasm.